Literature DB >> 28337739

Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology.

Yasuni Nakanuma1,2, Katsuhiko Uesaka3, Shiro Miyayama4, Hiroshi Yamaguchi5, Masayuki Ohtsuka6.   

Abstract

Invasive biliary tract carcinomas are usually tubular adenocaricnomas with abundant desmoplastic reactions and frequent ductal and periductal invasion at the time of the diagnosis. Recently, several intraductal neoplasms of the bile duct, particularly at a pre-invasive stage, have been recognized. They include intraductal papillary neoplasm of the bile duct (IPNB), biliary intraepithelial neoplasm (BilIN), and others, such as intraductal tubulopapillary neoplasm (ITPN) of the bile duct. IPNBs are grossly visible predominantly intraductal-growing papillary neoplasms covered by well-differentiated neoplastic epithelium with fine fibrovascular cores in the dilated bile ducts. Regarding their similarities to intraductal papillary mucinous neoplasm of the pancreas (IPMN) of main pancreatic duct type, some IPNBs resemble IPMN ("pancreatic type"), while others are only somewhat similar or variably different from IPMN ("non-pancreatic type"). Some IPNBs develop via a common oncogenic signaling pathway, and others, particularly those of intestinal type, frequently show GNAS mutations, as in IPMN. BilINs are a microscopically recognizable flat or micropapillary pre-invasive neoplasm and are presumed to precede conventional nodular-sclerosing cholangiocarcinomas. ITPN of the bile duct is a rare neoplasm composed of densely packed tubular glands. These three types of neoplasms are not infrequently associated with invasive adenocarcinoma. Pre-invasive intraglandular neoplasms of the peribiliary glands, another epithelial system in the biliary tree, have been also reported. Further characterization of these intraductal and intraglandular neoplasms of the bile duct is needed to overcome devastating invasive biliary tract carcinoma.

Entities:  

Mesh:

Year:  2017        PMID: 28337739     DOI: 10.14670/HH-11-892

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  10 in total

Review 1.  Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.

Authors:  Gábor Lendvai; Tímea Szekerczés; Idikó Illyés; Réka Dóra; Endre Kontsek; Alíz Gógl; András Kiss; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; Katalin Borka
Journal:  Pathol Oncol Res       Date:  2018-11-17       Impact factor: 3.201

Review 2.  [Precancerous and early stage cancer of the bile duct system].

Authors:  H-M Tautenhahn; S Brückner; F Rauchfuß; F Donndorf; M Ardelt; R Fahrner; A Tannapfel; U Settmacher
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

3.  Planned limited resection of the extrahepatic bile duct in a case of intraductal papillary neoplasm of the bile duct based on preoperative examinations.

Authors:  Atsushi Nanashima; Naoya Imamura; Masahide Hiyoshi; Takeomi Hamada; Koichi Yano; Takashi Wada; Hiroshi Kawakami; Tesshin Ban; Yoshimasa Kubota; Yuichiro Sato; Kenichi Harada
Journal:  Clin J Gastroenterol       Date:  2019-10-09

4.  Clinicopathological findings and imaging features of intraductal papillary neoplasms in bile ducts.

Authors:  Honghui Zhang; Zhendong Zhong; Gaoyin Kong; Junaid Khan; Lianhong Zou; Yu Jiang; Xiehong Liu; Yixun Tang; Bo Jiang; Chuang Peng; Yinghui Song; Sulai Liu
Journal:  PeerJ       Date:  2020-09-30       Impact factor: 2.984

Review 5.  Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls.

Authors:  Susan Shyu; Aatur D Singhi
Journal:  Hum Pathol       Date:  2020-12-28       Impact factor: 3.526

Review 6.  Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.

Authors:  Yasuni Nakanuma; Yuko Kakuda; Katsuhiko Uesaka
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

Review 7.  Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct.

Authors:  Yuji Sakai; Masayuki Ohtsuka; Harutoshi Sugiyama; Rintaro Mikata; Shin Yasui; Izumi Ohno; Yotaro Iino; Jun Kato; Toshio Tsuyuguchi; Naoya Kato
Journal:  World J Gastroenterol       Date:  2021-04-21       Impact factor: 5.742

8.  Whole-exome sequencing for a more accurate diagnosis of intraductal papillary neoplasms of the bile duct.

Authors:  Tomoaki Matsumori; Norimitsu Uza; Nobuyuki Kakiuchi; Toshihiro Morita; Yoshihiro Nishikawa; Masahiro Shiokawa; Kojiro Taura; Yuzo Kodama; Hiroshi Seno
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-04-10

Review 9.  Benign biliary neoplasms and biliary tumor precursors.

Authors:  Samantha Sarcognato; Diana Sacchi; Matteo Fassan; Luca Fabris; Massimiliano Cadamuro; Giacomo Zanus; Ivana Cataldo; Claudia Covelli; Paola Capelli; Alberto Furlanetto; Maria Guido
Journal:  Pathologica       Date:  2021-06

Review 10.  Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.

Authors:  Mukul Vij; Yogesh Puri; Ashwin Rammohan; Gowripriya G; Rajesh Rajalingam; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  World J Gastrointest Oncol       Date:  2022-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.